Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance

BACKGROUND: High-throughput assays for the SARS-CoV-2 virus are critical to increasing test capacity and slowing the spread of COVID-19. Abbott Molecular developed and received emergency use authorization (EUA) to deploy the new RealTime SARS-CoV-2 assay, run on the automated m2000sp/rt system. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Degli-Angeli, Emily, Dragavon, Joan, Huang, Meei-Li, Lucic, Danijela, Cloherty, Gavin, Jerome, Keith R., Greninger, Alexander L., Coombs, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395853/
https://www.ncbi.nlm.nih.gov/pubmed/32504946
http://dx.doi.org/10.1016/j.jcv.2020.104474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395853/
https://www.ncbi.nlm.nih.gov/pubmed/32504946
http://dx.doi.org/10.1016/j.jcv.2020.104474

Ejemplares similares